Author(s):
AM Avachat, SB Bhise
Email(s):
prof_avachat@yahoo.com
DOI:
Not Available
Address:
AM Avachat1* and SB Bhise2
1Department of Pharmaceutics, Sinhgad College of Pharmacy, Pune, 411 041, Maharashtra, India
2Govt. College of Pharmacy, Karad, 415124, Maharashtra, India
*Corresponding Author
Published In:
Volume - 1,
Issue - 3,
Year - 2009
ABSTRACT:
Rifampicin (RMP) and Isoniazid (INH) are highly unstable in liquid dosage form and there is no liquid product available. A novel concept of formulating a suspension of RMP and INH for pediatric and geriatric application has been tried. The reconstitutable dry syrup which can be reconstituted by using a special vehicle has shown very good stability at 2-80C and at 250C for more than 1 month and 14 days respectively using a stability indicating HPLC method. The in vitro dissolution studies have revealed no adverse impact of special vehicle on dissolution. Thus this combination product could prove to be a major boost for the market need for pediatric patients.
Cite this article:
AM Avachat, SB Bhise. Development and Characterization of a Stable Suspension of Rifampicin and Isoniazid. Research J. Pharma. Dosage Forms and Tech. 2009; 1(3):213-216.
Cite(Electronic):
AM Avachat, SB Bhise. Development and Characterization of a Stable Suspension of Rifampicin and Isoniazid. Research J. Pharma. Dosage Forms and Tech. 2009; 1(3):213-216. Available on: https://rjpdft.com/AbstractView.aspx?PID=2009-1-3-10